Initial Dose of Three Monthly Intravitreal Injections versus PRN Intravitreal Injections of Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion

Purpose. To compare visual and anatomic outcomes of intravitreal bevacizumab injections administered as needed (PRN group) and initial treatment with 3 monthly injections followed by as-needed injections (3 monthly initial dose group) in patients with macular edema (ME) secondary to branch retinal v...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Seong Joon, Ahn, Jeeyun, Woo, Se Joon, Park, Kyu Hyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770007/
https://www.ncbi.nlm.nih.gov/pubmed/24066287
http://dx.doi.org/10.1155/2013/209735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770007/
https://www.ncbi.nlm.nih.gov/pubmed/24066287
http://dx.doi.org/10.1155/2013/209735

Ejemplares similares